List view / Grid view



Lipid-based formulations: Their advantages in early development

21 March 2017 | By Kaspar van den Dries PhD, Senior Director and Principal Scientist, Solid Dose Development, Patheon

Patheon's Kaspar van den Dries shows the advantages of considering lipid formulation in early development to optimise a molecule’s developability...

Squeezing ROI from your serialisation initiative

8 March 2017 | By Mark Davison, CEO, Blue Sphere Health Ltd

Blue Sphere Health’s CEO, Mark Davison, outlines how to achieve positive return on investment (ROI) from a cost-effective serialisation initiative…

Live stream from Pittcon 2017

6 March 2017 | By Niamh Marriott, Junior Editor

We’re live at PITTCON 2017! Check this stream for live updates of the event…

UPDATE: The Cancer Drugs Fund

1 March 2017 | By Niamh Louise Marriott, Digital Editor

This page will be updated as the results from the Cancer Drugs Fund appraisal are announced by The National Institute of Health and Care Excellence (NICE).

Send this to a friend